Titan Medical Inc (TMDIF)

[MagnusProfitis]

“Looking forward, we are focused on clarifying expectations with the FDA for human clinical studies, currently planned to commence in the first half of 2022, and on the completion of the final milestone associated with the Medtronic development and license agreement, anticipated by year-end," McNally explained. "Our vision of commercializing a leading edge innovative robotic single access surgical system in an underserved market is closer to being achieved through recent progress and planned actions," McNally added.”

- IDE pushed back a quarter
- Final mile stone is delayed until the end of the year.
- as per the last sentence, the company is likely at hardware design freeze +.

#NotQuiteThereYet
#BigMacDroppingBreadCrumbsAboutMoreDelays